X0306 4 2013-07-01 0 0001434868 Esperion Therapeutics, Inc. ESPR 0001399763 Alta Partners VIII, L.P. ONE EMBARCADERO CENTER 37TH FLOOR SAN FRANCISCO CA 94111 0 0 1 0 0001399894 Alta Partners Management VIII, LLC ONE EMBARCADERO CENTER 37TH FLOOR SAN FRANCISCO CA 94111 0 0 1 0 0001198321 CHAMPSI FARAH ONE EMBARCADERO CENTER 37TH FLOOR SAN FRANCISCO CA 94111 0 0 1 0 0001198330 NOHRA GUY P ONE EMBARCADERO CENTER, 37TH FLOOR SAN FRANCISCO CA 94111 0 0 1 0 Common Stock 2013-07-01 4 C 0 1816475 A 1816475 I See footnote Common Stock 2013-07-01 4 P 0 235714 14.00 A 2052189 I See footnote Series A Preferred Stock 2013-07-01 4 C 0 1816475 0 D Common Stock 1816475 0 I See footnote Warrant to Purchase Preferred Stock 1 2013-07-01 4 J 0 497666 0 D 2018-02-12 Series A Preferred Stock 497666 0 I See footnote Warrant to Purchase Common Stock 6.99 2013-07-01 4 J 0 71237 0 A 2018-02-12 Common Stock 71237 71237 I See footnote The Series A Preferred Stock was automatically converted into Common Stock on a 6.986-for-1 basis upon the closing of the Issuer's initial public offering without payment of further consideration and had no expiration date. These securities are held of record by Alta Partners VIII, L.P. ("APVIII"). Alta Partners Management VIII, LLC ("APMVIII") is the general partner of APVIII. Guy Nohra, Daniel Janney and Farah Champsi are managing directors of APMVIII and exercise shared voting and investment power with respect to the shares owned by APVIII. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his or its proportionate pecuniary interest therein. Mr. Janney, as a director of the Issuer, files Section 16 reports separately. Upon the closing of the Issuer's initial public offering, this warrant to purchase shares of Series A Preferred Stock automatically converted on a 6.986-for-1 basis into a warrant to purchase shares of Common Stock, and the exercise price automatically adjusted accordingly. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrant and the change in exercise price. The warrant is immediately exercisable. By Alta Partners Management VIII, LLC, by /s/ Guy Nohra, managing director 2013-07-01 /s/ Daniel Janney, managing director 2013-07-01 /s/ Guy Nohra, managing director 2013-07-01 /s/ Farah Champsi, managing director 2013-07-01